ADM Positions Postbiotics at the Centre of Personalised Nutrition at Vitafoods Europe 2026

Why It Matters

Postbiotics are moving from specialty supplements into everyday foods, giving manufacturers a scalable, science‑backed way to meet personalized health demands and capture the high‑spending GLP‑1 consumer segment.

Key Takeaways

• ADM showcases postbiotic‑infused barista syrup for digestive health.
• New stress‑sleep‑mood gummy uses CPT305 postbiotic for nighttime routine.
• SIP‑of‑wellness shot blends fiber and BPL1 postbiotic for metabolism.
• Consumer awareness low, but purchase intent jumps to 80% after education.
• GLP‑1 users seek functional foods; 80% willing to pay premium.

Summary

At Vitafoods Europe 2026, ADM’s global VP of marketing, June, highlighted postbiotics as the centerpiece of the company’s personalized nutrition strategy, positioning them alongside probiotics and prebiotics to meet rising consumer demand for targeted health benefits.

ADM unveiled three flagship formats: a sugar‑free barista syrup infused with the S4in‑1 postbiotic for digestive comfort; a nighttime gummy containing the CPT305 postbiotic aimed at stress, sleep and mood; and a “SIP‑of‑wellness” shot that pairs a prebiotic fiber with the BPL1 postbiotic to support metabolic health, weight management and satiety. The same CPT305 ingredient is backed by eight clinical studies across women’s health stages, illustrating how a single postbiotic can be personalized for diverse populations.

June noted that European consumer awareness of postbiotics sits at just 44%, yet exposure drives purchase intent to nearly 80%. She also cited GLP‑1 users—who are highly motivated and 80% willing to pay a premium—as a fast‑growing segment seeking functional foods that mitigate cravings, support muscle maintenance and provide digestive comfort.

The push to embed scientifically validated postbiotics into everyday formats signals a shift from niche supplements to mainstream food and beverage products. For manufacturers, the dual focus on education and versatile ingredient platforms opens sizable growth opportunities, especially as GLP‑1 therapies reshape consumer expectations around nutrition and weight management.

Original Description

At Vitafoods Europe 2026, ADM showcased how advances in microbiome science help brands meet increasingly personalised consumer health needs. Through featured concepts, ADM highlighted microbiome solutions targeting stress, sleep, mood, digestive health, metabolic health, women’s health, active nutrition and more.

ADM centred on the growing role of postbiotics in delivering targeted everyday health benefits in convenient formats. Unlike conventional probiotics, postbiotics can retain functionality under challenging formulation conditions.

Among the standout concepts was a sugar-free “Barista Syrup” formulated with ADM’s Esflorin1™A Postbiotic (Bifidobacterium longum CECT7347), which may help support overall gut and digestive health, along with the potential for supporting reduced bloating.1

“Now consumers can get digestive health into their everyday coffee ritual,” said June Lin, Vice President, Global Innovation Marketing, ADM. “So, that’s what we mean when we say that functional nutrition is moving into consumers’ everyday life.”

ADM also showcased its “Zen Gummies” concept, featuring Lactobacillus gasseri CP2305 Postbiotic, designed to support stress, sleep and mood.2,3,4 The concept reflects demand for accessible, lifestyle-friendly alternatives to traditional supplement delivery formats, particularly for evening routines.

In addition, ADM presented its “Sip of Wellness” concept, formulated with ADM/Matsutani LLC’s Fibersol®B Prebiotic dietary fibreC and BPL1™D Postbiotic (Bifidobacterium animalis subsp. lactis CECT8145). The concept targets factors relevant to satiety5 and metabolic health6, addressing consumer needs linked to GLP-1 use and post-GLP-1 nutrition support.